Related Experiment Video
Updated: Jul 13, 2026
06:17
Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling
Joseph Tam1, Victoria Trembovler, Vincenzo Di Marzo
1Bone Laboratory, Hadassah School of Dental Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Summary
Traumatic brain injury (TBI) stimulates bone formation by increasing 2-arachidonoylglycerol (2-AG) and reducing norepinephrine (NE) via CB1 receptors. This mechanism enhances bone healing by alleviating sympathetic inhibition.
Area of Science:
- Neuroscience
- Skeletal Biology
- Endocrinology
Background:
- Cannabinoid CB1 receptors are present in bone sympathetic terminals.
- Traumatic brain injury (TBI) enhances osteogenesis and fracture healing in humans.
- Sympathetic nervous system activity influences bone metabolism.
Purpose of the Study:
- To investigate the role of endocannabinoids and CB1 receptors in TBI-induced bone formation.
- To elucidate the mechanism by which TBI stimulates bone formation at distant skeletal sites.
- To understand the interplay between sympathetic signaling and bone metabolism following TBI.
Main Methods:
- Assessment of bone formation markers and endocannabinoid levels in wild-type and CB1-null mice after TBI.
- Administration of 2-arachidonoylglycerol (2-AG) and beta-adrenergic receptor agonists.
- Measurement of norepinephrine (NE) levels in bone sympathetic terminals.
- Analysis of diacylglycerol lipases expression.
Main Results:
- TBI acutely stimulates bone formation in distant skeletal sites.
- TBI increases 2-arachidonoylglycerol (2-AG) and decreases norepinephrine (NE) levels preceding bone formation.
- TBI-induced bone formation is absent in CB1-null mice and can be mimicked by 2-AG administration.
- Isoproterenol restrains TBI- and 2-AG-induced osteogenesis, suggesting NE's inhibitory role via beta2-adrenergic receptors.
Conclusions:
- Sympathetic control of bone formation is regulated by 2-AG activation of prejunctional CB1 receptors.
- Elevated bone 2-AG suppresses NE release, alleviating sympathetic inhibition of bone formation.
- This pathway represents a novel mechanism for TBI-induced bone healing and offers therapeutic targets.
Related Concept Videos
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:16Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...